179 related articles for article (PubMed ID: 32685527)
1. Prognostic and Predictive Value of Cadherin 11 for Patients with Gastric Cancer and Its Correlation with Tumor Microenvironment: Results from Microarray Analysis.
Feng Z; Li X; Ren Z; Feng J; He X; You C
Biomed Res Int; 2020; 2020():8107478. PubMed ID: 32685527
[TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNA RP11-789C1.1 Suppresses Epithelial to Mesenchymal Transition in Gastric Cancer Through the RP11-789C1.1/MiR-5003/E-Cadherin Axis.
Chen Z; Wu J; Huang W; Peng J; Ye J; Yang L; Yuan Y; Chen C; Zhang C; Cai S; He Y; Wu S; Song W
Cell Physiol Biochem; 2018; 47(6):2432-2444. PubMed ID: 29991048
[TBL] [Abstract][Full Text] [Related]
3. Integrated microRNA network analyses identify a poor-prognosis subtype of gastric cancer characterized by the miR-200 family.
Song F; Yang D; Liu B; Guo Y; Zheng H; Li L; Wang T; Yu J; Zhao Y; Niu R; Liang H; Winkler H; Zhang W; Hao X; Chen K
Clin Cancer Res; 2014 Feb; 20(4):878-89. PubMed ID: 24352645
[TBL] [Abstract][Full Text] [Related]
4. Decreased Expression of Caveolin-1 and E-Cadherin Correlates with the Clinicopathologic Features of Gastric Cancer and the EMT Process.
Zhang K; Yang G; Wu W; Zhang J; Xia X; Jiang T; Cao J; Huang K; Qiu Z; Huang C
Recent Pat Anticancer Drug Discov; 2016; 11(2):236-44. PubMed ID: 26817615
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of altering epithelial-mesenchymal transition in metastatic lymph nodes of gastric cancer.
Okubo K; Uenosono Y; Arigami T; Yanagita S; Matsushita D; Kijima T; Amatatsu M; Uchikado Y; Kijima Y; Maemura K; Natsugoe S
Gastric Cancer; 2017 Sep; 20(5):802-810. PubMed ID: 28247164
[TBL] [Abstract][Full Text] [Related]
6. WNT5A is a key regulator of the epithelial-mesenchymal transition and cancer stem cell properties in human gastric carcinoma cells.
Kanzawa M; Semba S; Hara S; Itoh T; Yokozaki H
Pathobiology; 2013; 80(5):235-44. PubMed ID: 23615002
[TBL] [Abstract][Full Text] [Related]
7. HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway.
Yang SW; Zhang ZG; Hao YX; Zhao YL; Qian F; Shi Y; Li PA; Liu CY; Yu PW
Oncotarget; 2017 Feb; 8(6):9535-9545. PubMed ID: 28076840
[TBL] [Abstract][Full Text] [Related]
8. Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo.
Chen JH; Huang WC; Bamodu OA; Chang PM; Chao TY; Huang TH
BMC Cancer; 2019 Jun; 19(1):634. PubMed ID: 31248373
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-encoded miR-BART11 promotes tumor-associated macrophage-induced epithelial-mesenchymal transition via targeting FOXP1 in gastric cancer.
Song Y; Li Q; Liao S; Zhong K; Jin Y; Zeng T
Virology; 2020 Sep; 548():6-16. PubMed ID: 32530809
[TBL] [Abstract][Full Text] [Related]
10. Roles of E-cadherin and Noncoding RNAs in the Epithelial-mesenchymal Transition and Progression in Gastric Cancer.
Bure IV; Nemtsova MV; Zaletaev DV
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212809
[TBL] [Abstract][Full Text] [Related]
11. GM130 regulates epithelial-to-mesenchymal transition and invasion of gastric cancer cells via snail.
Zhao J; Yang C; Guo S; Wu Y
Int J Clin Exp Pathol; 2015; 8(9):10784-91. PubMed ID: 26617790
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of N-cadherin expression in gastric cancer.
Kamikihara T; Ishigami S; Arigami T; Matsumoto M; Okumura H; Uchikado Y; Kita Y; Kurahara H; Kijima Y; Ueno S; Natsugoe S
Pathol Int; 2012 Mar; 62(3):161-6. PubMed ID: 22360503
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of dysadherin expression in gastric cancer patients.
Shimada Y; Yamasaki S; Hashimoto Y; Ito T; Kawamura J; Soma T; Ino Y; Nakanishi Y; Sakamoto M; Hirohashi S; Imamura M
Clin Cancer Res; 2004 Apr; 10(8):2818-23. PubMed ID: 15102690
[TBL] [Abstract][Full Text] [Related]
14. EZH2-mediated epigenetic suppression of EphB3 inhibits gastric cancer proliferation and metastasis by affecting E-cadherin and vimentin expression.
Zhao K; He J; Wang YF; Jin SD; Fan Y; Fang N; Qian J; Xu TP; Guo RH
Gene; 2019 Feb; 686():118-124. PubMed ID: 30408551
[TBL] [Abstract][Full Text] [Related]
15. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated TIPE2 overexpression inhibits gastric cancer metastasis via reversal of epithelial-mesenchymal transition.
Yin H; Huang X; Tao M; Hu Q; Qiu J; Chen W; Wu J; Xie Y
Cancer Gene Ther; 2017 Apr; 24(4):180-188. PubMed ID: 28186089
[TBL] [Abstract][Full Text] [Related]
17. A novel tumor-based epithelial-to-mesenchymal transition score that associates with prognosis and metastasis in patients with Stage II/III colorectal cancer.
Roseweir AK; Kong CY; Park JH; Bennett L; Powell AGMT; Quinn J; van Wyk HC; Horgan PG; McMillan DC; Edwards J; Roxburgh CS
Int J Cancer; 2019 Jan; 144(1):150-159. PubMed ID: 29992570
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori-induced epithelial-mesenchymal transition, a potential role of gastric cancer initiation and an emergence of stem cells.
Choi YJ; Kim N; Chang H; Lee HS; Park SM; Park JH; Shin CM; Kim JM; Kim JS; Lee DH; Jung HC
Carcinogenesis; 2015 May; 36(5):553-63. PubMed ID: 25784376
[TBL] [Abstract][Full Text] [Related]
19. The clinical significance of vimentin-expressing gastric cancer cells in bone marrow.
Iwatsuki M; Mimori K; Fukagawa T; Ishii H; Yokobori T; Sasako M; Baba H; Mori M
Ann Surg Oncol; 2010 Sep; 17(9):2526-33. PubMed ID: 20358301
[TBL] [Abstract][Full Text] [Related]
20. Charactering tumor microenvironment reveals stromal-related transcription factors promote tumor carcinogenesis in gastric cancer.
Liu H; Ni S; Wang H; Zhang Q; Weng W
Cancer Med; 2020 Jul; 9(14):5247-5257. PubMed ID: 32463580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
